Anaqua forms partnership to trial COVID-19 medicines
Anaqua's ideaPoint has formed a strategic partnership with specialised clinical trials company WideTrial, in order to drive
greater access to investigational medicines for physicians and patients dealing with COVID-19 worldwide.
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.